Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives

NB Fernandes, Y Nayak, S Garg, UY Nayak - Coordination Chemistry …, 2023 - Elsevier
The field of advanced nanotechnology is brimming with a plethora of nanotheranostics
whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But …

[HTML][HTML] Nanomedicine as an emerging technology to foster application of essential oils to fight cancer

K AbouAitah, W Lojkowski - Pharmaceuticals, 2022 - mdpi.com
Natural prodrugs extracted from plants are increasingly used in many sectors, including the
pharmaceutical, cosmetic, and food industries. Among these prodrugs, essential oils (EOs) …

Non-ionic surfactant-assisted controlled release of oxyresveratrol on dendritic fibrous silica for topical applications

F Kerdmuanglek, T Chomtong, S Boonsith… - Journal of Colloid and …, 2023 - Elsevier
We present a simple and eco-friendly method for controlled drug release using a surfactant-
assisted method. Oxyresveratrol (ORES) was co-loaded with a non-ionic surfactant onto …

[HTML][HTML] Optimization of nanoparticles for smart drug delivery: a review

L Jia, P Zhang, H Sun, Y Dai, S Liang, X Bai, L Feng - Nanomaterials, 2021 - mdpi.com
Nanoparticle delivery systems have good application prospects in the treatment of various
diseases, especially in cancer treatment. The effect of drug delivery is regulated by the …

A drug delivery system based on poly-L-lysine grafted mesoporous silica nanoparticles for quercetin release

C Carucci, G Sechi, M Piludu, M Monduzzi… - Colloids and Surfaces A …, 2022 - Elsevier
This work focuses on the preparation of a pH-sensitive antimicrobial drug delivery system
based on Mesoporous silica nanoparticles (MSN), functionalized with aminopropyl …

[HTML][HTML] Isorhamnetin and anti-PD-L1 antibody dual-functional mesoporous silica nanoparticles improve tumor immune microenvironment and inhibit YY1-mediated …

H Liu, J Han, Y Lv, Z Zhao, S Zheng, Y Sun… - Journal of …, 2023 - Springer
Background The immune checkpoint inhibitor (ICI) anti-PD-L1 monoclonal antibody can
inhibit the progress of hepatocellular carcinoma (HCC). Epithelial–mesenchymal …

Gingerol/letrozole-loaded mesoporous silica nanoparticles for breast cancer therapy: In-silico and in-vitro studies

I Akbarzadeh, AS Poor, M Khodarahmi… - Microporous and …, 2022 - Elsevier
In this study, in-silico properties of Gingerol (Gin) and Letrozole (Let), as two potential anti-
cancer drugs, were investigated and some significant ADME drawbacks were predicted …

[HTML][HTML] Review on the protective activity of osthole against the pathogenesis of osteoporosis

J Chen, X Liao, J Gan - Frontiers in Pharmacology, 2023 - frontiersin.org
Osteoporosis (OP), characterized by continuous bone loss and increased fracture risk, has
posed a challenge to patients and society. Long-term administration of current …

[HTML][HTML] Doxorubicin-loaded silica nanocomposites for cancer treatment

V Popova, Y Poletaeva, A Chubarov, D Pyshnyi… - Coatings, 2023 - mdpi.com
Silica nanoparticles (SiNPs) are a promising material for nanomedicine technology. SiNPs
are considered a powerful tool for drug delivery, functional coatings and films, and …

Nanomicrobiology: emerging trends in microbial synthesis of nanomaterials and their applications

A Tauseef, F Hisam, T Hussain, A Caruso… - Journal of Cluster …, 2023 - Springer
Blossoming advancements and implementation of technologies in nanosciences have
thrown open avenues for the nano-revolution, which divulge the contribution of …